Antiangiogenic Herbal Composition Ob-X Reduces Abdominal Visceral Fat in Humans: A Randomized, Double-Blind, Placebo-Controlled Study

Figure 4

The fat reducing effect of placebo and Ob-X treatment in relation to the initial abdominal fat area. Correlation between the induced change in visceral fat and initial visceral fat before intervention of placebo (a) or Ob-X (b). Correlation between the induced change in subcutaneous fat and initial subcutaneous fat before intervention of placebo (c) or Ob-X (c). Correlation between the induced change in total abdominal fat and initial total abdominal fat before intervention of placebo (e) or Ob-X (f).

(a)

(b)

(c)

(d)

(e)

(f)